Recombinant Human HO2 Protein，His

The study of the HO2 (Heme Oxygenase 2) recombinant protein is rooted in its critical role in cellular physiology and pathology. As a member of the heme oxygenase family, HO2 is responsible for the catabolism of heme into biliverdin, carbon monoxide (CO), and free iron, processes that are crucial for maintaining cellular homeostasis and protecting against oxidative stress. Unlike its counterpart HO1, which is highly inducible under stress conditions, HO2 is constitutively expressed in various tissues, particularly in the brain and vascular systems, suggesting its involvement in neuroprotection and vasodilation. The exploration of HO2 recombinant protein is significant for elucidating its enzymatic mechanisms and regulatory pathways, which can offer insights into its potential therapeutic applications. Dysregulation of HO2 has been linked to several diseases, including neurodegenerative disorders and cardiovascular diseases, making it a compelling target for drug development. By producing HO2 as a recombinant protein, researchers can study its structure-function relationships, assess its kinetic properties, and explore its interactions with various molecules, thereby advancing our understanding of its biological roles and therapeutic potential. The ability to generate HO2 in a controlled manner facilitates high-throughput screening and the development of novel therapeutic strategies aimed at modulating its activity for disease intervention. Overall, the research on HO2 recombinant protein not only enhances our understanding of heme metabolism but also opens avenues for exploring innovative treatments for conditions associated with its dysregulation.